ConductScience.org, home

Paper3933818

A phase I trial of recombinant gamma interferon in patients with cancer.

Foon KA and 7 others. Cancer Immunol Immunother, 1985. Cited by 103 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A phase I trial of recombinant gamma interferon in patients with cancer. Papers, record 3933818. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3933818

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A phase I trial of recombinant gamma interferon in patients with cancer.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
103
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2024-04-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Foon KAK A
2Sherwin SAS A
3Abrams PGP G
4Stevenson HCH C
5Holmes PP
6Maluish AEA E
7Oldham RKR K
8Herberman RBR B

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon-gammaMajor topic
NeoplasmsMajor topic
Recombinant ProteinsMajor topic
Drug Evaluation
Humans
Immunotherapy

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N01-CO-23910NCI NIH HHSUnited StatesN01CO023910PubMed and NIH

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,159,812Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.Ann Intern Med1980https://conductscience.org/library/papers/6159812PubMed
26,403,609Recombinant interferon-gamma increases HLA-DR synthesis and expression.J Immunol1983https://conductscience.org/library/papers/6403609PubMed
36,752,447A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.JAMA1982https://conductscience.org/library/papers/6752447PubMed
46,427,223Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation.J Biol Chem1984https://conductscience.org/library/papers/6427223PubMed
56,332,565Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.Ann Intern Med1984https://conductscience.org/library/papers/6332565PubMed
66,192,145Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.J Clin Invest1983https://conductscience.org/library/papers/6192145PubMed
791,516Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells.Eur J Immunol1979https://conductscience.org/library/papers/91516PubMed
86,319,748Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.J Virol1984https://conductscience.org/library/papers/6319748PubMed
96,168,319Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.Blood1981https://conductscience.org/library/papers/6168319PubMed
106,178,592Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6178592PubMed
11362,211Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.N Engl J Med1978https://conductscience.org/library/papers/362211PubMed
126,689,734Alpha interferon for induction of remission in hairy-cell leukemia.N Engl J Med1984https://conductscience.org/library/papers/6689734PubMed
136,342,490Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial.Ann Intern Med1983https://conductscience.org/library/papers/6342490PubMed
146,336,662Renal cell carcinoma: antitumor effects of leukocyte interferon.Cancer Res1983https://conductscience.org/library/papers/6336662PubMed
156,470,751Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.J Clin Oncol1984https://conductscience.org/library/papers/6470751PubMed
166,091,541
Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Antiviral Res1984https://conductscience.org/library/papers/6091541PubMed
176,835,320Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.N Engl J Med1983https://conductscience.org/library/papers/6835320PubMed
18468,410Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients.Int J Cancer1979https://conductscience.org/library/papers/468410PubMed
1984,901Interferon therapy in myelomatosis.Lancet1979https://conductscience.org/library/papers/84901PubMed
206,430,557Pharmacokinetic study of partially pure gamma-interferon in cancer patients.Cancer Res1984https://conductscience.org/library/papers/6430557PubMed

See all 30 references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.

PMIDTitleJournalYearIn PapersSource
42,480,219Long-acting pegylated interferon gamma sensitizes AML cells to killing by donor T cells.Blood Adv2026https://conductscience.org/library/papers/42480219PubMed
39,885,917Successful treatment of a chronic myeloid leukemia patient with extreme thrombocytosis by a combination of imatinib and interferon‑α: A case report.Exp Ther Med2025https://conductscience.org/library/papers/39885917PubMed
38,487,528A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.Front Immunol2024https://conductscience.org/library/papers/38487528PubMed
36,481,777Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex.Sci Rep2022https://conductscience.org/library/papers/36481777PubMed
36,003,373Substratum interactions determine immune response to allogeneic transplants of endothelial cells.Front Immunol2022https://conductscience.org/library/papers/36003373PubMed
35,747,815Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins.Front Oncol2022https://conductscience.org/library/papers/35747815PubMed
34,909,751Solar UVR and Variations in Systemic Immune and Inflammation Markers.JID Innov2021https://conductscience.org/library/papers/34909751PubMed
34,068,946Data-Driven Mathematical Model of Osteosarcoma.Cancers (Basel)2021https://conductscience.org/library/papers/34068946PubMed
33,291,412Data Driven Mathematical Model of Colon Cancer Progression.J Clin Med2020https://conductscience.org/library/papers/33291412PubMed
33,110,704Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/33110704PubMed
31,827,180Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells.Sci Rep2019https://conductscience.org/library/papers/31827180PubMed
31,324,057
Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect).
Cancers (Basel)2019https://conductscience.org/library/papers/31324057PubMed
29,484,738Anti-cancer therapy with TNFα and IFNγ: A comprehensive review.Cell Prolif2018https://conductscience.org/library/papers/29484738PubMed
27,821,803Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.Oncotarget2016https://conductscience.org/library/papers/27821803PubMed
26,015,966Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice.Mol Ther Methods Clin Dev2014https://conductscience.org/library/papers/26015966PubMed
25,294,906MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.Clin Cancer Res2014https://conductscience.org/library/papers/25294906PubMed
23,570,383Interferon-γ-induced necrosis: an antitumor biotherapeutic perspective.J Interferon Cytokine Res2013https://conductscience.org/library/papers/23570383PubMed
22,160,384B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.Blood2012https://conductscience.org/library/papers/22160384PubMed
18,279,103Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.J Interferon Cytokine Res2008https://conductscience.org/library/papers/18279103PubMed
11,454,803Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.Gut2001https://conductscience.org/library/papers/11454803PubMed

See all 30 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA13,439PubTator's text mininghttps://conductscience.org/library/genes/3439

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3933818

GET https://conductscience.org/api/papers/v1/3933818/references?page=2